Navigation Links
Varian Medical Systems Schedules First Quarter FY2009 News Release and Conference Call
Date:12/10/2008

PALO ALTO, Calif., Dec. 10 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) announced today that it will report results for first quarter of fiscal year 2009 following the close of regular trading on Thursday, January 29, 2009. The news release will be followed by a teleconference available to all interested parties at 2:00 p.m. PT.

The Varian Medical Systems quarterly results can be accessed on January 29, 2009. The news release and information on the conference call webcast will be available on the company website at: www.varian.com/investor. Details on the conference call and replay follow:

    Teleconference:   Telephone from within the U.S.:
                      -- Dial 1-866-271-0675 and enter access code
                         46529406 prior to the call at
                         2:00 p.m. PT/5:00 p.m. ET.
                         Telephone from outside the U.S.:
                      -- Dial 1-617-213-8892 and enter access code
                         46529406 prior to the call at
                         2:00 p.m. PT/5:00 p.m. ET.
                      *Note: If the number of lines allocated to the
                      call is exhausted, the webcast or replay should be
                      utilized.

    Replay:           The teleconference will be rebroadcast until
                      8:00 p.m. ET, Friday, January 30, 2009 and can be
                      accessed by phone or Web link as follows:
                      -- Telephone from within the U.S.: Dial
                         1-888-286-8010 and enter access code 54317886.
                      -- Telephone from outside the U.S.: Dial
                         1-617-801-6888 and enter access code 54317886.
                      -- Internet: Click on the "Quarterly Conference Call"
                         icon on the company's investor relations website
                         at www.varian.com/investor
                      -- Web conferences will be archived on the company
                         website for a year.

For automatic "e-mail alerts" regarding Varian news and events investors can subscribe on the company website: http://varian.investorroom.com/index.php?s=58.

For additional information contact Anne Rambo at 650-424-5834 or anne.rambo@varian.com.

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,800 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/.

    FOR INFORMATION CONTACT:
    Spencer Sias, (650) 424-5782
    Vice President, Corporate Communications
    and Investor Relations
    spencer.sias@varian.com


'/>"/>
SOURCE Varian Medical Systems
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NEW Line of Pushbutton Pill Cases Launched by Variant Products
2. Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto
3. Few Ontario women with invasive ovarian cancer referred for genetic testing of breast cancer genes
4. International study supports new standard of treatment for women with advanced ovarian cancer
5. Study unmasks how ovarian tumors evade immune system
6. Varian Medical Systems to Exhibit the Latest X-Ray Image Detectors, X-Ray Tubes, and Cancer Treatment Technologies at RSNA This Year
7. Ortho Biotech Announces NDA Submission for Trabectedin for the Treatment of Relapsed Ovarian Cancer
8. New platinum-phosphate compounds kill ovarian cancer cells
9. Protein compels ovarian cancer cells to cannibalize themselves
10. Top Indian Cancer Hospital to Introduce Advanced Radiosurgery Treatments With Novalis Tx from Varian Medical Systems and BrainLAB
11. Varian Medical Systems Schedules Fiscal Year End Review in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
Breaking Medicine Technology: